Assignee
GLAXOSMITHKLINE IP DEV LTD
GB·208 granted patents·213 pending applications·642 citations·filing 2013–2025
Top patents by PatentIndex Score
421 records- 0197US10336744B21AP E3 ligase directed proteolysis targeting chimeric moleculesGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 2, 2019·50 cites·2 claims
- 0296US9789100B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Oct 17, 2017·30 cites·18 claims
- 0396US9771424B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 26, 2017·30 cites·20 claims
- 0496US9738718B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 22, 2017·33 cites·20 claims
- 0596US9556152B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 31, 2017·29 cites·20 claims
- 0696US9035063B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted May 19, 2015·55 cites·8 claims
- 0795US9718848B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 1, 2017·30 cites·31 claims
- 0895US9624202B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 18, 2017·25 cites·26 claims
- 0994US11365190B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jun 21, 2022·3 cites·18 claims
- 1094US8937071B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 20, 2015·59 cites·15 claims
- 1193US11492361B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Nov 8, 2022·3 cites·24 claims
- 1293US10981901B1Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 20, 2021·7 cites·10 claims
- 1392US11697665B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jul 11, 2023·3 cites·20 claims
- 1491US11970480B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Granted Apr 30, 2024·2 cites·16 claims
- 1591US10870663B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Dec 22, 2020·3 cites·12 claims
- 1691US10513517B2Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 24, 2019·11 cites·3 claims
- 1790US10485806B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Nov 26, 2019·3 cites·10 claims
- 1890US10189820B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jan 29, 2019·9 cites·8 claims
- 1990US9994607B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jun 12, 2018·10 cites·16 claims
- 2089US10047115B2Cyclic dinucleotides useful for the treatment of inter alia cancerGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 14, 2018·12 cites·9 claims
- 2189US9988376B2Benzothiophene derivatives as estrogen receptor inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 5, 2018·9 cites·21 claims
- 2289US9914781B1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 13, 2018·10 cites·6 claims
- 2388US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 2488US10272095B2NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 30, 2019·4 cites·18 claims
- 2587US10933070B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 2, 2021·2 cites·4 claims
- 2687US10640812B2Processes for the production of oligonucleotidesGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 5, 2020·3 cites·16 claims
- 2787US9993514B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 12, 2018·11 cites·12 claims
- 2887US9737505B2Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Aug 22, 2017·4 cites·16 claims
- 2987US9382238B2Pyridine derivatives as rearranged during transfection (RET) kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 5, 2016·9 cites·4 claims
- 3086US10899716B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 26, 2021·2 cites·2 claims
- 3186US10364266B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 30, 2019·5 cites·11 claims
- 3286US9102668B2Polymorphs and saltsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Aug 11, 2015·3 cites·4 claims
- 3385US10858631B2Methods for adeno-associated viral vector productionGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 8, 2020·5 cites·32 claims
- 3485US10590085B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 17, 2020·3 cites·31 claims
- 3585US10023568B2Naphthyridine derivatives useful as αvβ6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 17, 2018·5 cites·39 claims
- 3685US9216965B2Amino-quinolines as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2013·Granted Dec 22, 2015·9 cites·16 claims
- 3784US11547704B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 10, 2023·1 cites·4 claims
- 3884US11229646B2Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dioneGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 25, 2022·1 cites·5 claims
- 3984US11130811B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Sep 28, 2021·1 cites·18 claims
- 4084US10683360B2Targeted protein degradationGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jun 16, 2020·4 cites·11 claims
- 4184US10450312B2Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 22, 2019·3 cites·82 claims
- 4284US10450341B2Cyclic di-nucleotides as modulators of STINGGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 22, 2019·6 cites·13 claims
- 4384US10292987B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 21, 2019·4 cites·10 claims
- 4484US10144733B2Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Dec 4, 2018·5 cites·13 claims
- 4584US2024300965A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 4683US11111262B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Sep 7, 2021·1 cites·4 claims
- 4783US10940154B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 9, 2021·3 cites·4 claims
- 4883US9956209B2Compounds αv β6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted May 1, 2018·4 cites·10 claims
- 4983US9918974B2Pyridone derivatives as rearranged during transfection (RET) kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Mar 20, 2018·3 cites·19 claims
- 5083US2023242642A1Antigen binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 421 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GLAXOSMITHKLINE IP DEV LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →